Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Gruenenthal patent reports new CRAC inhibitors

March 2, 2015

RepliCel Life Sciences submits clinical trial application for RCS-01

Feb. 25, 2015

Israelian team reports throphoblast-derived microparticles

Feb. 19, 2015

VBL Therapeutics reports data from VB-201 trials in psoriasis and ulcerative colitis

Feb. 18, 2015

Phase II trial of MRX-6 in pediatric atopic dermatitis does not reach primary endpoint

Feb. 18, 2015

Dermira releases phase IIb results of DRM-04

Feb. 10, 2015

Akaal Pharma reports data from phase I trial of AKP-11 in psoriasis

Feb. 9, 2015

FDA to review sNDA for psoriasis candidate tofacitinib

Feb. 9, 2015

Brickell Biotech holds financing round, begins study of BBI-4000

Feb. 9, 2015

InMed begins program targeting Epidermolysis bullosa simplex

Feb. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...